pipamperone
Small moleculeexperimental
Pipamperone, sold under the brand name Dipiperon, is a typical antipsychotic of the butyrophenone family used in the treatment of schizophrenia and as a sleep aid for depression. It is or has been marketed under brand names including Dipiperon, Dipiperal, Piperonil, Piperonyl, and Propitan. Pipamperone was discovered at Janssen Pharmaceutica in 1961, and entered clinical trials in the United States in 1963. — Wikipedia
Clinical trial activity
5 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
2
Phase 4
1
Earliest trial started Feb 1, 2008 (NCT00672659)
Timeline
Indications
Approved for
Mechanism of action
- Serotonin 2a (5-HT2a) receptorINHIBITOR
HTR2A inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
NC(=O)C1(N2CCCCC2)CCN(CCCC(=O)c2ccc(F)cc2)CC1- Mol. weight
- 375.49 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaPipamperone ↗
- ChEMBLCHEMBL440294 ↗
Also known as
- 1'-(3-(4-fluorobenzoyl)propyl)-(1,4'-bipiperidine) -4'-carboxamide
- carpiperone
- carpiperone
- dipiperal
- dipiperon
- dipiperon
- dipiperone
- floropipamide
- floropipamide
- floropipamide
- floropipamide
- fluoropipamide
- fluoropipamide
- pipamperone
- pipamperone
- pipamperone
- pipamperone
- pipamperone
- pipamperone
- pipamperone
- pipamperone
- pipamperone dihydrochloride
- pipamperone hcl
- pipamperone hcl
- pipamperone hcl
- pipamperone hydrochloride
- pipamperon-neuraxpharm
- pipaneperone
- pipaneperone
- r 3345
- r-3345
- r-3345
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02435095 | Phase 4 | May 1, 2015 | RWTH Aachen University |
| NCT02374567 | Phase 3 | Jan 1, 2015 | Gottfried Wilhelm Leibniz Universität Hannover |
| NCT01450514 | Phase 2 | Mar 1, 2012 | Katholieke Universiteit Leuven, PharmaNeuroBoost N.V. |
| NCT01312922 | Phase 3 | Sep 1, 2011 | PharmaNeuroBoost N.V. |
| NCT00672659 | Phase 2 | Feb 1, 2008 | CPS Research, PharmaNeuroBoost N.V. |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| PharmaNeuroBoost N.V. | For profit | 3 | 3 | 2 | 2008 |
| CPS Research | For profit | 1 | 0 | 1 | 2008 |
| Gottfried Wilhelm Leibniz Universität Hannover | Academic/Hospital | 1 | 1 | 1 | 2015 |
| Katholieke Universiteit Leuven | Academic/Hospital | 1 | 0 | 1 | 2012 |
| RWTH Aachen University | Academic/Hospital | 1 | 1 | 1 | 2015 |
5 organizations
Page 1 / 1